Stock Scorecard
Stock Summary for Mimedx Group Inc (MDXG) - $9.06 as of 11/20/2024 8:25:44 PM EST
Total Score
15 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for MDXG
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MDXG
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MDXG
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MDXG
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for MDXG (34 out of 90)
Stock Price Rating (Max of 10) | 4 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 0 |
Book Value (Max of 10) | 2 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 0 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 3 |
Trading Volume (Max of 10) | 8 |
Price to Earnings (Max of 10) | 8 |
Latest News for for MDXG
Financial Details for MDXG
Company Overview |
|
---|---|
Ticker | MDXG |
Company Name | Mimedx Group Inc |
Country | USA |
Description | MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 9.06 |
Price 4 Years Ago | 9.08 |
Last Day Price Updated | 11/20/2024 8:25:44 PM EST |
Last Day Volume | 963,708 |
Average Daily Volume | 836,246 |
52-Week High | 9.49 |
52-Week Low | 5.47 |
Last Price to 52 Week Low | 65.63% |
Valuation Measures |
|
Trailing PE | 16.04 |
Industry PE | 52.46 |
Sector PE | 40.32 |
5-Year Average PE | -35.57 |
Free Cash Flow Ratio | 15.10 |
Industry Free Cash Flow Ratio | 35.05 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 4.10 |
Total Cash Per Share | 0.60 |
Book Value Per Share Most Recent Quarter | 1.23 |
Price to Book Ratio | 7.53 |
Industry Price to Book Ratio | 5.44 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 3.98 |
Industry Price to Sales Ratio Twelve Trailing Months | 13.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 5 |
Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
Total Shares Outstanding | 146,946,000 |
Market Capitalization | 1,331,330,760 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -9.70% |
Annual Earnings Growth | 292.83% |
Reported EPS 12 Trailing Months | 0.57 |
Reported EPS Past Year | 0.24 |
Reported EPS Prior Year | 0.32 |
Net Income Twelve Trailing Months | 88,458,000 |
Net Income Past Year | 58,228,000 |
Net Income Prior Year | -30,197,000 |
Quarterly Revenue Growth YOY | 2.90% |
5-Year Revenue Growth | -2.59% |
Operating Margin Twelve Trailing Months | 0.14 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 88,801,000 |
Total Cash Past Year | 82,000,000 |
Total Cash Prior Year | 65,950,000 |
Net Cash Position Most Recent Quarter | 70,783,000 |
Net Cash Position Past Year | 32,000,000 |
Long Term Debt Past Year | 50,000,000 |
Long Term Debt Prior Year | 50,000,000 |
Total Debt Most Recent Quarter | 18,018,000 |
Equity to Debt Ratio Past Year | 0.74 |
Equity to Debt Ratio Most Recent Quarter | 0.91 |
Total Stockholder Equity Past Year | 142,717,000 |
Total Stockholder Equity Prior Year | -17,988,000 |
Total Stockholder Equity Most Recent Quarter | 181,008,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 50,460,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.34 |
Free Cash Flow Past Year | 24,788,000 |
Free Cash Flow Prior Year | -19,407,000 |
Options |
|
Put/Call Ratio | 0.88 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.49 |
MACD Signal | 0.34 |
20-Day Bollinger Lower Band | 4.97 |
20-Day Bollinger Middle Band | 6.64 |
20-Day Bollinger Upper Band | 8.32 |
Beta | 1.94 |
RSI | 81.18 |
50-Day SMA | 7.22 |
150-Day SMA | 5.55 |
200-Day SMA | 6.58 |
System |
|
Modified | 11/19/2024 6:30:05 AM EST |